
POMHEX
CAS No. 2004714-34-3
POMHEX( —— )
Catalog No. M34848 CAS No. 2004714-34-3
Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and selective ENO2 inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 225 | Get Quote |
![]() ![]() |
5MG | 345 | Get Quote |
![]() ![]() |
10MG | 512 | Get Quote |
![]() ![]() |
25MG | 803 | Get Quote |
![]() ![]() |
50MG | 1086 | Get Quote |
![]() ![]() |
100MG | 1458 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePOMHEX
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and selective ENO2 inhibitor.
-
DescriptionPOMHEX, a racemic mixture and a cell-permeable pivaloyloxymethyl (POM) proagent of HEX, is a potent, ENO2-specific inhibitor of enolase. POMHEX exhibits low-nanomolar potency against ENO1-deleted cells in vitro and is capable of eradicating ENO1-deleted xenografted tumours in vivo. POMHEX is a potent glycolysis inhibitor.
-
In VitroCell Proliferation Assay Cell Line:ENO1-deleted (D423, red), ENO1-isogenically rescued (D423 ENO1, blue) and ENO1-WT (LN319, grey) cells.Concentration:78 nM.Incubation Time:8 h.Result:Down-regulated cell density.
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetGlucokinase
-
RecptorGlucokinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2004714-34-3
-
Formula Weight423.4
-
Molecular FormulaC17H30NO9P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (236.18 mM; Ultrasonic )
-
SMILESO=C(OCOP(=O)(OCOC(=O)C(C)(C)C)C1C(=O)N(O)CCC1)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu-Hsi Lin, et al. An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Nat Metab. 2020 Nov 23.?
molnova catalog



related products
-
Naringinase
Naringinase, a hydrolytic enzymatic complex, possesses the activity of both α-L-rhamnosidase and β-D-glucosidase. Naringinase has wide occurrence in nature. Naringinase can be used in the biotransformation of steroids, antibiotics, and mainly on glycoside
-
(1S,2R)-Globalagliat...
(1S,2R)-Globalagliatin is a highly potent glucokinase (GK) activator for the study of type 2 diabetes.
-
YZ9
Y29 is a potent PFKFB3 inhibitor with an IC50 of 0.183 μM, and acts as a competitive inhibitor against Fru-6-P with a Ki of 0.094 μM.